Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 06/10/21 12:00:00 on US and Canada Markets.
Plans to acquire MediaDonuts. The acquisition of MediaDonuts, which is expected to close July 1st, will establish the company as a Digital Marketing company in Southeast Asia, moving beyond its traditional Hispanic oriented media businesses. We estimate that the acquisition in total will be ro...
SANTA MONICA, Calif.--(BUSINESS WIRE)-- Entravision Communications Corporation (NYSE: EVC) (“Entravision” or “the Company”) announced today that the Company has entered into a definitive agreement to acquire MediaDonuts, a leading digital marketing performance and b...
Investor Forum at the World Stem Cell Summit - June 17, 2021 - presented by Channelchek - Featuring Avalon GloboCare, Caladrius Biosciences, CellZ, Celularity, ExoProTher, GID BIO, Longeveron, Medicinal Cells, Inc., Mesoblast Read More >>
Virtual road show. Noble and Channelchek recently hosted a fascinating virtual roadshow featuring Mr. Chris Taylor, President and CEO of Great Bear Resources, which is in the final months of shallow resource drilling. Great Bear has released results for 318 LP Fault drill holes to date and exp...
Investor Forum at the World Stem Cell Summit - June 17, 2021 - presented by Channelchek - Featuring Avalon GloboCare, Caladrius Biosciences, CellZ, Celularity, ExoProTher, GID BIO, Longeveron, Medicinal Cells, Inc., Mesoblast Read More >>
Developing drugs to stop the signals that lead to tumor cell growth. Onconova has two drugs in clinical testing, ON 123300 and rigosertib, which target pathways between the cell surface and DNA transcription. These drugs are in clinical trials for both cancers affecting large populations and a...
PDS Biotech presented the first analysis from the Phase 2 trial testing PDS0101 in HPV16+ (human papilloma virus 16 positive) cancers. The data presentation was from the first 25 patients out of the target enrollment of 56 patients. The trial enrolls patients who have failed first-line treatme...
PDS Biotech presented the first analysis from the Phase 2 trial testing PDS0101 in HPV16+ (human papilloma virus 16 positive) cancers. The data presentation was from the first 25 patients out of the target enrollment of 56 patients. The trial enrolls patients who have failed first-line treatme...
NEWTOWN, Pa., June 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM), (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced its participation in Noble Capital Markets’ Virtual R...
MELVILLE, N.Y.--(BUSINESS WIRE)--Jun. 8, 2021-- June 8, 2021-- Comtech Telecommunications Corp. (NASDAQ: CMTL) today reported its operating results for the third fiscal quarter ended April 30, 2021 and updated its financial targets for fiscal 2021. Read More >>
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
20.92%Change Percent:
Snap Inc. Class A Company Name:
SNAP Stock Symbol:
NYSE Market:
snap.com Website: